Walleye Capital LLC I Teos Therapeutics, Inc. Transaction History

Walleye Capital LLC

  • $54.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$16.57 - $35.1 $1.14 Million - $2.42 Million
-68,891 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$31.92 - $47.45 $1.11 Million - $1.64 Million
34,638 Added 101.12%
68,891 $2.22 Million
Q4 2021

Mar 03, 2022
BUY
$26.23 - $47.86 $898,456 - $1.64 Million
34,253 New
34,253 $0

Others Institutions Holding ITOS

# of Institutions
142
Shares Held
30.2M
Call Options Held
84.6K
Put Options Held
32.2K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $528M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email